IRCCS, MultiMedica, PST-Via Fantoli 16/15, 20138, Milan, MI, Italy.
Institute of Clinical Physiology, National Research Council (CNR), 20162, Milan, Italy.
Cardiovasc Diabetol. 2022 Mar 4;21(1):35. doi: 10.1186/s12933-022-01465-0.
The prevalence of prediabetes is increasing in the global population and its metabolic derangements may expose to a higher risk to develop type 2 diabetes (T2D) and its cardiovascular burden. Lifestyle modifications might have considerable benefits on ameliorating metabolic status. Alternative biomarkers, such as circulating miR-21, has been recently discovered associated with dysglycemia. Here we evaluated, in a longitudinal cohort of dysglycemic population the relation between the circulating miR-21/ROS/HNE levels and the habit-intervention (HI) after 1 year of follow-up.
1506 subjects from DIAPASON study were screened based on the Findrisc score. Of them, 531 subjects with Findrisc ≥ 9 were selected for dysglycemia (ADA criteria) and tested for circulating miR-21, ROS and HNE levels, as damaging-axis. 207 subjects with dysglycemia were re-evaluated after 1-year of habit intervention (HI). Repeated measures tests were used to evaluate changes from baseline to 1-year of follow-up. The associations between glycemic parameters and miR-21/ROS/HNE were implemented by linear regression and logistic regression models.
After HI, we observed a significant reduction of miR-21/ROS/HNE axis in dysglycemic subjects, concomitantly with ameliorating of metabolic parameters, including insulin resistance, BMI, microalbuminuria, reactive hyperemia index and skin fluorescence. Significant positive interaction was observed between miR-21 axis with glycaemic parameters after HI. Lower miR-21 levels after HI, strongly associated with a reduction of glycemic damaging-axis, in particular, within-subjects with values of 2hPG < 200 mg/dL.
Our findings demonstrated that HI influenced the epigenetic changes related to miR-21 axis, and sustain the concept of reversibility from dysglycemia. These data support the usefulness of novel biological approaches for monitoring glycemia as well as provide a screening tool for preventive programmes.
全球人口中糖尿病前期的患病率正在增加,其代谢紊乱可能使发生 2 型糖尿病(T2D)及其心血管负担的风险更高。生活方式的改变可能对改善代谢状况有相当大的益处。替代生物标志物,如循环 miR-21,最近被发现与糖代谢异常有关。在这里,我们在一个糖尿病前期人群的纵向队列中评估了循环 miR-21/ROS/HNE 水平与 1 年后随访的习惯干预(HI)之间的关系。
根据 Findrisc 评分,从 DIAPASON 研究中筛选出 1506 名受试者。其中,有 531 名 Findrisc≥9 的受试者被选入糖尿病前期(ADA 标准),并检测循环 miR-21、ROS 和 HNE 水平,作为损伤轴。207 名糖尿病前期患者在 1 年后进行习惯干预(HI)的再评估。采用重复测量检验评估从基线到 1 年随访的变化。通过线性回归和逻辑回归模型,评估血糖参数与 miR-21/ROS/HNE 之间的相关性。
在 HI 后,我们观察到糖尿病前期患者的 miR-21/ROS/HNE 轴显著降低,同时代谢参数也得到改善,包括胰岛素抵抗、BMI、微量白蛋白尿、反应性充血指数和皮肤荧光。HI 后观察到 miR-21 轴与血糖参数之间存在显著的正交互作用。HI 后 miR-21 水平降低,与血糖损伤轴的降低密切相关,特别是在 2hPG<200mg/dL 的患者中。
我们的研究结果表明,HI 影响与 miR-21 轴相关的表观遗传变化,并支持从糖尿病前期恢复的概念。这些数据支持使用新的生物学方法监测血糖,并为预防计划提供筛查工具。